DV
Dividend Vision

BJDX — Bluejay Diagnostics Inc

Bluejay Diagnostics Inc (BJDX)

Total return is -100.0% over the past 4.8 years, 178.6 points behind SPY at 78.6%. Its deepest 1-year drawdown was 93.9%.

Bluejay Diagnostics is a medical diagnostics company that develops the Symphony technology platform, which includes an analyzer and single-use cartridges designed to measure key diagnostic biomarkers in blood samples for critical care and other clinical settings. The company does not currently distribute dividends. This security appeals to investors seeking exposure to diagnostic technology and medical device innovation rather than income-generating equities.

BJDX key facts

Asset type
Stock
Asset class
Equity
Inception date
11/10/2021
Last close
$1.05
Market cap
$1,500,336
Average volume
166300.0
Last dividend
$0.0975
Beta
0.875
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.74